Reuters logo
BRIEF--Adocia and Lilly announce positive results from Phase 1b study of Lispro U100
2016年4月27日 / 下午4点31分 / 2 年前

BRIEF--Adocia and Lilly announce positive results from Phase 1b study of Lispro U100

April 27 (Reuters) - Adocia Sa

* Adocia and Lilly announce positive results from a Phase 1b study of repeated administration of ultra-rapid biochaperone Lispro U100 in people with type 2 diabetes Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below